**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 156-10-5 |P-nitrosodiphenylamine | 75 | 205-848-7 |
|----------------|--------------------------------------|----------|-----------|
| 7732-18-5 |Water | Balance | 231-791-2 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XN
Risk Phrases: 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Limited evidence of a carcinogenic effect.Cancer suspect agent.The
toxicological properties of this material have not been fully
investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. The toxicological properties of this
material have not been fully investigated.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. The toxicological properties of this substance have not
been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated.
Chronic:
May cause cancer according to animal studies.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. If irritation
develops, get medical aid.
Skin:
Flush skin with plenty of water for at least 15 minutes while
removing contaminated clothing and shoes. Wash clothing before
reuse. Get medical aid if symptoms occur.
Ingestion:
Call a poison control center. If swallowed, do not induce vomiting
unless directed to do so by medical personnel. Never give anything by
mouth to an unconscious person. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash hands before eating. Use only in a well-ventilated area.
Minimize dust generation and accumulation. Avoid breathing dust,
vapor, mist, or gas. Keep container tightly closed. Keep away from
heat, sparks and flame. Wash clothing before reuse.
Storage:
Keep away from sources of ignition. Store in a cool, dry,
well-ventilated area away from incompatible substances. Keep
containers tightly closed.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 156-10-5:
CAS# 7732-18-5:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear nitrile-latex gloves, apron, and/or clothing.
Clothing:
Wear nitrile-latex gloves, apron, and/or clothing.
Respirators:
Wear a NIOSH/MSHA or European Standard EN 149
approved full-facepiece airline respirator in the
positive pressure mode with emergency escape
provisions. Follow the OSHA respirator regulations
found in 29 CFR 1910.134 or European Standard EN 149.
Use a NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Flakes
Color: brown green
Odor: benzene-like
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 144 deg C dec
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature: > 145 deg C
Solubility in water: slightly soluble
Specific Gravity/Density:
Molecular Formula: C12H10N2O
Molecular Weight: 198.22
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, excess heat.
Incompatibilities with Other Materials:
Strong acids, strong bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 156-10-5: JK0175000
CAS# 7732-18-5: ZC0110000
LD50/LC50:
CAS# 156-10-5: Draize test, rabbit, eye: 100 mg/24H Moderate.
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
Carcinogenicity:
P-nitrosodiphenylamine -
California: carcinogen, initial date 1/1/88
Water -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 156-10-5: No information available.
CAS# 7732-18-5: No information available.
Canada
CAS# 156-10-5 is listed on Canada's NDSL List.
CAS# 7732-18-5 is listed on Canada's DSL List.
CAS# 156-10-5 is listed on Canada's Ingredient Disclosure List.
CAS# 7732-18-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 156-10-5 is listed on the TSCA inventory.
CAS# 7732-18-5 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 3/20/1998 Revision #3 Date: 12/03/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Glycidol, tech.
| 556-52-5 |
|
N-(2-Chloroacetyl)-L-tyrosine
| 1145-56-8 |
|
Acriflavine hydrochloride 23-24.5% chlorin e
| 8063-24-9 |
|
4-Nitrosodiphenylamine, Tech. 75% Remainder Water
| 156-10-5 |
|
4-Nitrophenylhydrazine hydrochloride, 98% (titr.)
| 636-99-7 |
|
4-Pyrrolidinopyridine, 98%
| 2456-81-7 |
|
(4-Fluorophenyl)acetone, 98%
| 459-03-0 |
|
N-(4-Pyridyl)-Pyridinium Chloride Hydrochloride, Tech.
| 5421-92-1 |
|
4-Hydroxyvalerophenone
| 2589-71-1 |
|
2,5-Dimethylaniline, 99%
| 95-78-3 |
|
4-Phenylmorpholine, 98+%
| 92-53-5 |
|
Tributylphosphine oxide, 98%
| 814-29-9 |
|
5-Methoxygramine, 99%
| 16620-52-3 |
|
Durene-Alpha-1,Alpha-2-Dithiol, 97%
| 10230-61-2 |
|
(-)-Di-P-Toluoyl-L-Tartaric Acid, 97%
| 32634-66-5 |
|
Cyclopropyl Carbinol, 98%
| 2516-33-8 |
|
Octyltrichlorosilane, 97%
| 5283-66-9 |
|
(-)-Caryophyllene Oxide, 97%
| 13877-94-6 |
|
4-Acetamidoantipyrine, 97%
| 83-15-8 |
|
(-)-(2S,8AR)-(Camphorylsulfonyl)Oxaziridine, 99+% (99+% e.e.)
| 104372-31-8 |
|
Ethyl 2-Bromo-3-Methylbutyrate, 95% (GC)
| 609-12-1 |
|
Azadirachtin, 98% (HPLC)
| 11141-17-6 |
|
Heptamethyldisilazane, 99%
| 920-68-3 |
|
1-Nonen-3-Ol, 98%
| 21964-44-3 |
|
N-Methylanthranilic acid, 90%, balance mainly anthranilic acid
| 118-92-3 |
|
(Methylthio)-acetonitrile, 99%
| 35120-10-6 |
|
Alpha-Bromo-3'-Nitroacetophenone, 97%
| 2227-64-7 |
|
D(-)-Salicin, 99+%
| 138-52-3 |
|
Palatine Fast Yellow Bln
| 10127-05-6 |
|
3,3-Dichloro-2-Hydroxytetrahydropyran, 99+%
| 0-00-1 |
|
Ethyl isodehydracetate, 97%
| 3385-34-0 |
|
1-(3-Chloropropyl)-1,3-dihydro-2H-benzimidazol-2-one, balance mainly
| 62780-89-6 |
|
4-Amino-1,1-diethoxy-2-butyne, 96%
| 124744-14- |
|
2-Amino-3-Chloro-5-Trifluoromethylpyridine 98%
| 79456-26-1 |
|
m-Xylylenediamine, 99%
| 1477-55-0 |
|
Allyl methyl sulfide, 99%
| 10152-76-8 |
|
5-Bromo-2-Fluorobenzonitrile, 97%
| 179897-89-3 |
|
2,9-Dimethyl-4,7-Diphenyl-1,10-Phenanthroline, 98%
| 4733-39-5 |
|
Poly(butadiene), phenyl terminated
| 25038-44-2 |
|
2-tert-Butylphenol, 99%
| 88-18-6 |
|
D(+)-Fucose, 99%
| 3615-37-0 |
|
o-Tolidine
| 119-93-7 |
|
1-Bromopentadecane, 98%
| 629-72-1 |
|
Piperazine hexahydrate, 98%
| 142-63-2 |
|
4-(5)-Nitroindan, Mixture
| |
|
Ouabain Octahydrate, 96.0 -104.0% (On the Anhydrous Substance)
| 11018-89-6 |
|
Homovanillyl alcohol, 99%
| 2380-78-1 |
|
4-Methylimidazole, 98%
| 822-36-6 |
|
Levamisole hydrochloride, 99+%
| 16595-80-5 |
|
1,3-Butanediol, 99%
| 107-88-0 |
|
|